Modulation of T-regulatory cells by small molecules: potential therapy for GvHD

Modulation of T-regulatory cells by small molecules: potential therapy for GvHD

Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffering from blood cancers. Nonetheless, significant morbidity and mortality are still prevalent. One major complication is graft versus host disease (GvHD) which occurs in 30-70% of patients. In this dis...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Leuschner, U
Altri autori:	Roberts, D
Natura:	Tesi
Lingua:	English
Pubblicazione:	2021

Documenti analoghi

Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
di: Mauro Di Ianni, et al.
Pubblicazione: (2024-01-01)

The Role of Bacteria and Pattern Recognition Receptors in GvHD
di: E. Holler, et al.
Pubblicazione: (2010-01-01)

Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
di: Haroon Shaikh, et al.
Pubblicazione: (2022-11-01)

Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
di: Martin eSzyska, et al.
Pubblicazione: (2016-03-01)

Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
di: Kudakwashe Mhandire, et al.
Pubblicazione: (2021-10-01)

Antigen-specific priming is dispensable in depletion of apoptosis-sensitive T cells for GvHD prophylaxis
di: Shai eYarkoni, et al.
Pubblicazione: (2014-05-01)

Effect of the YCD3-1 Anti-Mouse Monoclonal on Murine GvHD
di: James P. Okunewick, et al.
Pubblicazione: (1993-07-01)

Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells
di: Satish Ranjan, et al.
Pubblicazione: (2017-08-01)

Spontaneous xenogeneic GvHD in Wilms' tumor Patient‐Derived xenograft models and potential solutions
di: Seyed Mostafa Monzavi, et al.
Pubblicazione: (2022-08-01)

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
di: Jongbok Lee, et al.
Pubblicazione: (2025-01-01)

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
di: Kottaridis, P, et al.
Pubblicazione: (2001)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
di: Ines Bojanic, et al.
Pubblicazione: (2023-02-01)

Accumulation of T-cell-suppressive PD-L1high extracellular vesicles is associated with GvHD and might impact GvL efficacy
di: Regina Jitschin, et al.
Pubblicazione: (2023-03-01)

The role of animal models in the study of hematopoietic stem cell transplantation and GvHD: A historical overview.
di: Margherita Boieri, et al.
Pubblicazione: (2016-08-01)

Campath 1 H "in the bag" is an effective method of GvHD prevention in allogeneic stem cell transplantation.
di: Potter, M, et al.
Pubblicazione: (2000)

HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis
di: Massimo Berger, et al.
Pubblicazione: (2022-02-01)

Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
di: Roberto Crocchiolo, et al.
Pubblicazione: (2021-03-01)

Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation
di: Sibéli de Fátima Ferraz Simão Proença, et al.

The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD following Hematopoietic Stem Cell Transplantation
di: Seyed Asadollah Mousavi, et al.
Pubblicazione: (2016-12-01)

Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety
di: Joni Keto, et al.
Pubblicazione: (2018-06-01)

Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
di: Robin Reschke, et al.
Pubblicazione: (2022-08-01)

FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition
di: Jaeyoon Ryu, et al.
Pubblicazione: (2020-06-01)

Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
di: Raffaella Greco, et al.
Pubblicazione: (2019-10-01)

Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation
di: Hemn Mohammadpour, et al.
Pubblicazione: (2023-03-01)

Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers
di: Yan-Ruide Li, et al.
Pubblicazione: (2022-09-01)

PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
di: Mohammad S Hossain, et al.
Pubblicazione: (2017-01-01)

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
di: Matthew Mankarious, et al.
Pubblicazione: (2020-01-01)

IL-10 mRNA Engineered MSCs Demonstrate Enhanced Anti-Inflammation in an Acute GvHD Model
di: Cuiping Zhang, et al.
Pubblicazione: (2021-11-01)

GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics
di: Sakhila Ghimire, et al.
Pubblicazione: (2021-10-01)

Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD
di: Sybille Landwehr-Kenzel, et al.
Pubblicazione: (2021-10-01)

18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)
di: Wolfgang Roll, et al.
Pubblicazione: (2021-09-01)

HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis
di: Hiroko Shike, et al.
Pubblicazione: (2024-12-01)

Impaired thymic iNKT cell differentiation at early precursor stage in murine haploidentical bone marrow transplantation with GvHD
di: Weijia Zhao, et al.
Pubblicazione: (2023-08-01)

In marrow aplasia reduced-intensity conditioning and T-cell depletion of cytokine mobilised stem cells provides good engraftment without GvHD
di: Novitzky, N, et al.
Pubblicazione: (2006)

Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD
di: Kati Hyvärinen, et al.
Pubblicazione: (2020-02-01)

Regulatory T Cells in GVHD Therapy
di: Wen-wen Guo, et al.
Pubblicazione: (2021-06-01)

Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study
di: Walter Spindelboeck, et al.
Pubblicazione: (2021-12-01)

Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells
di: Uwe Thiel, et al.
Pubblicazione: (2017-05-01)

Visual and ocular surface benefits of mini-scleral contact lenses in patients with chronic ocular graft-versus-host disease (GvHD)
di: Philip Keye, et al.
Pubblicazione: (2024-10-01)

Decreased Plasma Level of Cytokeratin 20 (KRT20) Is Indicative of the Emergence and Severity of Acute GvHD Irrespective to the Type of Organ Involvement
di: Nikolett Lupsa, et al.
Pubblicazione: (2022-02-01)